Prelude Therapeutics Incorporated

NasdaqGS:PRLD Stock Report

Market Cap: US$309.1m

Prelude Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:PRLD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 May 23BuyUS$9,790Krishna VaddiIndividual1,900US$5.31
24 May 23BuyUS$12,936Bryant LimIndividual2,400US$5.39
23 May 23BuyUS$66,749Krishna VaddiIndividual11,856US$5.63
23 May 23BuyUS$27,500Laurent ChardonnetIndividual5,000US$5.50
22 May 23BuyUS$4,999,999OrbiMed Advisors LLCCompany869,565US$5.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PRLD?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,9920.00727%
Individual Insiders3,252,2115.92%
General Public3,448,6116.28%
Institutions10,172,43318.5%
VC/PE Firms16,589,44230.2%
Hedge Funds21,426,89739%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.1%.


Top Shareholders

Top 25 shareholders own 91.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.5%
Baker Bros. Advisors LP
17,293,897US$97.4m0%1.22%
30.2%
OrbiMed Advisors LLC
16,589,442US$93.4m0%1.32%
7.53%
Deerfield Management Company, L.P. Series C
4,133,000US$23.3m0%0.48%
4.68%
Tavistock Life Sciences
2,568,287US$14.5m2.94%0.83%
3.94%
Krishna Vaddi
2,163,369US$12.2m0%no data
2%
BlackRock, Inc.
1,095,589US$6.2m2.54%no data
1.9%
T. Rowe Price Group, Inc.
1,042,737US$5.9m-2.26%no data
1.83%
The Vanguard Group, Inc.
1,006,856US$5.7m3.42%no data
1.01%
Blue Sky Trust, Endowment Arm
551,776US$3.1m0%no data
0.93%
Massachusetts Financial Services Company
510,749US$2.9m0.09%no data
0.91%
Paul Friedman
500,098US$2.8m0%no data
0.64%
Geode Capital Management, LLC
349,367US$2.0m5.52%no data
0.58%
Sio Capital Management, LLC
320,394US$1.8m-8.46%0.69%
0.56%
Andrew Combs
307,207US$1.7m0%no data
0.54%
Morgan Stanley, Investment Banking and Brokerage Investments
296,862US$1.7m22%no data
0.48%
FMR LLC
264,686US$1.5m0.04%no data
0.39%
Renaissance Technologies LLC
216,400US$1.2m55.3%no data
0.39%
State Street Global Advisors, Inc.
212,234US$1.2m13.4%no data
0.32%
Peggy Scherle
175,685US$989.1k0%no data
0.29%
TD Asset Management, Inc.
160,652US$904.5k0%no data
0.27%
Bridgeway Capital Management, LLC
148,749US$837.5k303%0.01%
0.24%
Jacobs Levy Equity Management Inc
131,307US$739.2k-8.79%no data
0.23%
Charles Schwab Investment Management, Inc.
124,700US$702.1k0%no data
0.21%
Northern Trust Global Investments
114,097US$642.4k-1.23%no data
0.18%
Millennium Management LLC
96,966US$545.9k51.8%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.